Background Gestational diabetes mellitus (GDM) is a serious health problem associated
with both foetal and maternal complications. New biomarkers that can predict or help in the …

Abstract Background: Angiopoietin-like protein 8 (ANGPTL8) is a circulatory hormone that
plays an important role in the proliferation of the pancreatic beta cells and lipid metabolism …

Abstract Gestational Diabetes Mellitus (GDM) is characterised by insulin resistance
accompanied by reduced beta-cell compensation to increased insulin demand, typically …

Gestational diabetes mellitus (GDM) causes both maternal and fetal adverse outcomes. The
deregulation of microRNAs (miRNAs) in GDM suggests their involvement in GDM …

Background Identifying effective regulatory mechanisms will be significant for Gestational
diabetes mellitus (GDM) diagnosis and treatment. Methods The expressions of miR‐22 and …

Gestational diabetes mellitus (GDM) is characterized by insulin resistance accompanied by
low/absent beta-cell compensatory adaptation to the increased insulin demand. Although …

miR-96-5p: A potential diagnostic marker for gestational dia... : Medicine miR-96-5p: A
potential diagnostic marker for gestational diabetes mellitus : Medicine Log in or Register …

Aim To explore whether plasma microRNA‐16‐5p,‐17‐5p and‐20a‐5p can be used as
diagnostic biomarkers in gestational diabetes mellitus (GDM) and to investigate the …

Abstract Background and Objective In recent years circulating microRNAs (miRNAs) have
attracted interest as biomarkers of metabolic disease. MiRNA expression varies across …

Background Gestational diabetes mellitus (GDM), which has been identified for the first time
during pregnancy and is defined as glucose intolerance of varying degrees, is one of the …